Osteopore (ASX:OSX) ROCE % : -249.06% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Osteopore ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Osteopore's annualized ROCE % for the quarter that ended in Jun. 2024 was -249.06%.

Osteopore ROCE % Historical Data

The historical data trend for Osteopore's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore ROCE % Chart

Osteopore Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-65.49

-32.15

-49.94

-111.01

-383.05

Osteopore Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial					-87.32	-162.15	-272.55	-273.77	-249.06

Osteopore ROCE % Calculation

Osteopore's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4.813	/	( ( (3.565 - 1.485)	+	(4.032 - 3.599) )	/ 2 )
	=	-4.813	/	( (2.08	+	0.433)	/ 2 )
	=	-4.813	/	1.2565
	=	-383.05 %

Osteopore's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-2.792	/	( ( (4.032 - 3.599)	+	(4.546 - 2.737) )	/ 2 )
	=	-2.792	/	( ( 0.433	+	1.809 )	/ 2 )
	=	-2.792	/	1.121
	=	-249.06 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Osteopore (ASX:OSX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Osteopore ROCE % Related Terms

Thank you for viewing the detailed overview of Osteopore's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Osteopore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Street Georges Terrace, Level 5, Perth, WA, AUS, 6000

Website

https://www.osteopore.com

Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore Headlines

No Headlines